October 1, 2021
Check out today’s FDA Law Blog
It’s got a great lawyers’-eye perspective on the ruling against the FDA in the MOU case. It’s great to see this getting more attention — it shows how important the issue is, and it’s now even more likely to get attention from Congress.
Read “The D.C. District Court Slaps Down on Procedural Grounds FDA’s 20-year Effort to Implement its Memorandum of Understanding to Address Interstate Shipments of Compounded Drug Products“.
(Of course, the best way to get Congress’s attention is to come to Compounders on Capitol Hill on November 2–3, where you can talk to your member of Congress face-to-face and explain it.)